HKETO Newsroom

June 15, 2022

Director of HKETO visits Ottawa for business promotion

Director of the Hong Kong Economic and Trade Office (Toronto) (HKETO), Ms Emily Mo, visited Ottawa on June 15 to promote Hong Kong as an ideal platform for Canadian companies to explore the ever-expanding healthcare and life science markets in Asia and Indo-Pacific region. 

Ms Mo spoke at the seminar entitled “Turning challenges into opportunities in Healthcare and Life Sciences" organised by the Hong Kong-Canada Business Association (HKCBA) Ottawa Section.  She updated participants on the latest development in Hong Kong, and talked about the strengths of the city as an ideal platform to Mainland China including the opportunities brought by the National 14th Five-Year Plan and the Guangdong-Hong Kong-Macao Greater Bay Area development.

She also introduced to participants the significant growth of the healthcare and life sciences sectors which are dominating in the IPO market. “The Hong Kong Stock Exchange allowed the listing of pre-revenue biotech companies in mid-2018, since then 48 pre-revenue biotech companies have listed, and Hong Kong has become the world’s second-largest funding hub for biotech after NASDAQ, and the largest hub in Asia,” Ms Mo said.

“In 2021, a total of 34 biotech and healthcare companies were listed in the Hong Kong Stock Exchange, and this made Hong Kong rank first by number of deals and second by amount of funds raised globally. 2021 was closed with a total of 92 biotech and healthcare listings on the Hong Kong Stock Exchange’s main board, raising a total of 32.6 billion USD,” Ms Mo continued.

“Regarding research and development, under the flagship project ‘InnoHK Research Clusters’ two clusters on healthcare technologies as well as the artificial intelligence (AI)

and robotics technologies were set up in the Hong Kong Science and Technology Park, attracting many top-notch universities and research institutions including the University of Waterloo,” Ms Mo said. 

Hong Kong is playing an increasingly significant role as a platform for doing business in Asia and Indo-Pacific.  Ms Mo encouraged Canadian companies to make use of the Hong Kong platform to explore the vast markets in these regions.

Before closing, Ms Mo introduced to participants that Year 2022 marks an important milestone for Hong Kong as the city is celebrating the 25th anniversary of the establishment of the Hong Kong Special Administrative Region. “The theme of ‘A New Era – Stability • Prosperity • Opportunity’ represents Hong Kong’s achievements over the past 25 years, and underscores our anticipation for and confidence in a brighter future,” Ms Mo said.

At the following panel discussion, Head of Investment Promotion of HKETO Mr Christopher Chen introduced to the audience the advantages of using Hong Kong as a platform for doing business in Asia and Indo-Pacific, as well as the business opportunities in the healthcare and life sciences sectors in Asia and beyond.

Before joining the seminar, Ms Mo paid a courtesy call to Senator of Canada, Mr Victor Oh, at the Parliament Hill. She briefed him on the latest developments in Hong Kong and exchanged views with him on issues with mutual interests.

June 15, 2022

香港經貿處處長到訪渥太華進行商務推廣

香港駐多倫多經濟貿易辦事處(香港經貿處)處長巫菀菁於六月十五日到訪渥太華,推廣香港是個理想平台,有助加拿大公司於亞洲及印度太平洋地區開拓發展迅速的醫療保健及生命科學的市場。

巫菀菁在港加商會(渥太華分會)舉辦題為「透過醫療保健及生命科學轉危為機」的研討會上致辭。她向與會者介紹香港的最新發展,並闡述香港是進軍中國內地市場理想平台的優勢,包括國家《十四五規劃綱要》及粵港澳大灣區發展帶來的龐大機遇。

此外,巫菀菁向與會者介紹醫療保健及生命科學領域的迅速發展情況,並在首次公開招股市場佔有主導地位。巫菀菁表示:「港交所在2018年中容許未有收入的生物科技公司在香港上市,自此,已有48家未有收入的生物科技公司在港交所上市,香港已成為僅次於納斯達克的全球第二大,以及及亞洲最大的生物科技融資中心。」

巫菀菁續說:「在2021年,共有34家生物科技及醫療保健公司在港交所上市,令香港在交投量方面排行全球第一,募集資金方面排行第二。在2021年年終,港交所的主板市場共有92家生物科技及醫療保健公司上市,集資總額達326億美元。」

巫菀菁表示:「在研發方面,香港科技園公司就醫療科技以及人工智能和機械人科技兩個範疇設立『InnoHK創新香港研發平台』,這項目已吸引許多世界知名的學府及科研機構,包括滑鐵盧大學。」

香港在亞洲及印度太平洋地區營商上擔當了一個越來越重要的平台角色,巫菀菁鼓勵加拿大公司善用香港平台拓展這些地區的龐大市場。

最後巫菀菁向與會者介紹2022年是香港特別行政區成立25周年的重要里程碑。她表示:「『砥礪奮進廿五載,攜手再上新征程』這主題不僅帶出香港二十五年來的成就,亦寄託着大家對更美好未來的熱切期盼和信心。」

投資推廣署加拿大辦事處投資推廣總監陳立智在的專題討論上,向與會者介紹香港作為平台在亞洲及印度太平洋地區營商的優勢,以及醫療保健及生命科學界在亞洲及以外地區的商機。

出席研討會前,巫菀菁在國會山莊拜會了加拿大參議員胡子修,向他簡介香港的最新發展,並就雙方共同關心的議題交換意見。